Mahai Chris LaVictoire

Reported to SECin USFilings at 4 companies

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

4
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
abrdn Life Sciences Investors—Open-market buy$10,498527 sharesJul 20, 2026abrdn Life Sciences Investors$10,498Buy · Jul 20Open-market buy527Jul 20, 2026
abrdn Healthcare Investors—Open-market buy$10,501501 sharesJul 20, 2026abrdn Healthcare Investors$10,501Buy · Jul 20Open-market buy501Jul 20, 2026
abrdn World Healthcare Fund—Open-market buy$10,507796 sharesJul 20, 2026abrdn World Healthcare Fund$10,507Buy · Jul 20Open-market buy796Jul 20, 2026
abrdn Healthcare Opportunities Fund—Open-market buy$10,502568 sharesJul 20, 2026abrdn Healthcare Opportunities Fund$10,502Buy · Jul 20Open-market buy568Jul 20, 2026